Team Cognigence

Why Cognigence Chose to Invest in Cancer Research: The Case for Funding the Gaps Big Pharma Won't Touch

Abstract Despite unprecedented advances in oncology, large segments of cancer research remain critically underfunded because pharmaceutical investment is concentrated primarily on commercially profitable cancer types and treatments. This article examines the structural gaps within modern cancer funding, including the neglect of rare cancers, prevention research, early-detection technologies and underserved

What Is SROI And Why Every Donor Should Be Asking for It

Abstract As philanthropy increasingly shifts toward accountability-driven giving, Social Return on Investment (SROI) is emerging as one of the most important frameworks for measuring whether charitable capital is producing real, measurable change. This article examines the limitations of traditional philanthropy models built primarily on trust, narrative reporting and activity-